阿达普特生物科技 ADPT
$27.98 +$1.15 (+4.29%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $27.98 0.00%
开盘$26.98
昨收$26.83
当日区间$26.54 – $28.27
成交量3.33M
市值$4.53B
市盈率（TTM）–
股息率–
ADPT 相关新闻
匹配 Adaptive Biotechnologies 或代码 ADPT 的头条新闻，按最新排序。
- Goldman Sachs Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $35
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $34
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $34 正面
- Adaptive Biotechnologies(ADPT.US) Officer Sells US$3.24 Million in Common Stock
- Craig-Hallum Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $27.5 正面
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $27.5
- A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $25 to $28
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $24 正面
- TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $25 正面
- Guggenheim Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $22 正面
- William Blair Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
- A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $19 to $22
- Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Cuts Target Price to $13.54 负面
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $20
暂无评论——快来第一个聊聊 ADPT。
登录后参与讨论。